Assyro AI

FDA Orange Book · active-ingredient family

Amlodipine besylate; benazepril hydrochloride

Amlodipine besylate; benazepril hydrochloride is approved as 1 brand and 12 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:LOTREL · NDA 020364

1

Brand (NDA)

12

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · capsule

ProductApplicantApplicationTEApproved
LOTRELRLD×6SANDOZNDA 020364Mar 03, 1995

Generic (ANDA) products (12)

ProductApplicantApplicationTEApproved
AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE×4AMNEALANDA 077215Dec 07, 2018
AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE×6HERITAGEANDA 091431ABDec 30, 2013
AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE×6AUROBINDO PHARMA LTDANDA 202239ABSep 05, 2012
AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE×2DR REDDYS LABS INCANDA 090149ABJul 05, 2011
AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE×2PHARMOBEDIENTANDA 079047Jul 05, 2011
AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE×2WATSON LABS INCANDA 090364ABJul 05, 2011
AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE×4WATSON LABSANDA 077890ABOct 14, 2010
AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE×6CHARTWELL RXANDA 078381Jul 29, 2010
AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE×4RISINGANDA 077375May 21, 2010
AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE×4DR REDDYS LABS INCANDA 077183ABApr 15, 2010
AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE×6LUPIN PHARMSANDA 078466ABFeb 05, 2010
AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE×6TEVA PHARMSANDA 077179May 18, 2007

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Amlodipine besylate; benazepril hydrochloride — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.